Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001159036-26-000029
Filing Date
2026-02-24
Accepted
2026-02-24 18:14:46
Documents
1
Period of Report
2026-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771974883.html 4  
1 FORM 4 wk-form4_1771974883.xml 4 11762
  Complete submission text file 0001159036-26-000029.txt   13551
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
LaBrosse Nicole (Reporting) CIK: 0001910662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 26673358